"hyderabad-company"

US-based unit of the drug major is recalling Acetaminophen Tablets (325 mg) in the US due to cGMP (Current Good Manufacturing Practices) deviations

Revenue from operations increased to Rs 1,197 crore for the fourth quarter as compared with Rs 1,176 crore in the year-ago period

Company’s board approved appointment of Subrahmanyam Sharma Tatapudi as Chief Technology Officer, effective 27 May 2025